This story is part of a special series celebrating the 10th anniversary of the Fast Company Innovation Festival. When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier ...

CRISPR co-creator Jennifer Doudna on watching her groundbreaking gene-editing technology help sickle cell patients: “It’s extraordinary.” Jennifer Doudna codeveloped the revolutionary gene ...

Jennifer Doudna, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold a portion of her holdings in the company. According to a recent SEC filing, Doudna sold 1,320 shares of Tempus AI's ...

Free admission - doors open at 7:00 p.m. Fundamental research to understand how bacteria fight viral infections uncovered the function of CRISPR-Cas programmable proteins that detect and cut specific ...

This course will take place virtually on Zoom. Participation in this course requires a device (ideally a computer or tablet, rather than a cell phone) with a camera and microphone in good working ...

It sounds like science fiction — and until 2012, the ability to cheaply and easily edit strings of DNA was exactly that. But as it turns out, CRISPR/Cas9 gene editing is a completely natural ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

The 2020 Nobel Prize for Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna for developing the method for genome editing. So far, the Nobel Assembly has awarded the Nobel ...